Cellulosic membrane |
(Unmodified) cuprophane membrane |
Cellulose |
Symmetric |
21 |
5–17 |
Low-flux (3.8 -8.4) |
Negligible middle molecule removal, significant complement activation and leukopenia, only for standard hemodialysis |
[56–58] |
Cellulose triacetate membrane |
Cellulose triacetate |
Symmetric |
58 ~ 78 |
15 |
Low- to high-flux (9.5–85.6) |
Minimal protein adsorption, attenuated complement activation, high antithrombotic performance, high phosphorus clearance, improved lipid metabolism |
[25, 59–62] |
Cellulose (di) acetate membrane |
Cellulose diacetate |
Symmetric |
NA |
14–30 |
Low- to high-flux |
Improved biocompatibility and hydrophobicity vs cuprophane membrane, low middle molecule removal |
[24, 63] |
Hemophan membrane |
Cellulose and diethylaminoethyl |
Symmetric |
21 |
5–20 |
Low-flux |
Negligible middle molecule removal, improved biocompatibility and hydrophobicity vs cuprophane membrane, higher pro-inflammatory cytokine production than polyamide membrane, only for standard hemodialysis |
[24] |
Cuprammonium rayon membrane |
Polyethylene and cellulose |
Asymmetric |
NA |
9–26 |
Low- to high-flux (9–19) |
Improved biocompatibility and hydrophobicity vs cuprophane membrane, less platelet activation and higher albumin loss vs polysulfone membrane |
[15, 24, 64, 65] |
Synthetic membrane |
AN69 membrane |
Copolymer of acrylonitrile and sodium methallyl sulfonate |
Symmetric |
25–55 |
30 |
High-flux (19.42) |
With a specific hydrogel structure on its surface; bulk adsorption of low-molecular-weight proteins such as cytokines; decreased complement activation, platelet adhesion and activation; increased activation of kallikrein-kinase system, production of bradykinin, available for high-flux hemodialysis, hemodiafiltration, and hemofiltration |
[24, 66] |
PAN membrane |
Copolymer of acrylonitrile, methacrylate and acrylic acid |
Asymmetric |
NA |
19–55 |
High-flux (45–54) |
Yield of bradykinin, risk of allergic reactions higher than other synthesis membranes, sustained mild complement activation |
[15, 67] |
PSF membrane |
Polysulfone, blending with polyvinylpyrrolidone or polyethylene glycol in most occasions |
Asymmetric |
NA |
30–104 |
Low- to high-flux |
Meets solute and fluid removal needs in all therapy modalities (low and high throughput dialysis, in-line hemofiltration and hemofiltration), efficient endotoxin retaining capacity, significant intrinsic biocompatibility, low cytotoxicity, the most widely used dialysis membrane in routine hemodialysis, Optimal chemical and thermal stability for steam sterilization, Increased β2 macroglobulin clearance through advanced PSF-based Helixone® without any albumin loss |
[6, 24, 26] |
PMMA membrane |
Isotactic and syndiotactic polymethylmethacrylate |
Asymmetric |
NA |
20–40 |
Low- to high-flux |
Reduced complement activation compared to cuprophane membranes with increased removal of β2 microglobulin by adsorption, sustained mild complement activation, and unexpected slight leukopenia |
[10, 15, 24, 28] |
PES membrane |
Polyethersulfone, blending with polyvinylpyrrolidone in most occasions |
Asymmetric |
NA |
30–104 |
Low- to high-flux |
Meets solute and fluid removal needs in all therapy modalities (low and high throughput dialysis, in-line hemofiltration and hemofiltration), provides significant intrinsic biocompatibility, favorable chemical and thermal stability, allows for steam sterilization, and delivers dialysate uniformly through Diapes® |
[24, 30] |
EVOH membrane |
Copolymer of ethylene and vinyl alcohol |
Symmetric |
NA |
25–32 |
Low-flux (5.8–11.1) |
Smooth inner surface; few plasma protein adsorption; weak interactions with blood cells |
[24, 68] |
|
MCO membrane |
Polyethersulfone, blending with polyvinylpyrrolidone |
Asymmetric |
50 |
35 |
High-flux (48–59) |
Medium apertures, uniform distribution of pores, steep sieve curve and internal filtration–backfiltration mechanism, greater removal of middle-molecule toxins than conventional high-flux dialysis, insufficient removal of protein-bound and large-molecule uremic toxins and unwanted albumin loss |
[31, 33] |
Bioactive membrane |
AN69ST membrane |
Copolymer of acrylonitrile and methallylsulfonate (AN69) coated with polyethyleneimine |
Symmetric |
NA |
45 |
High-flux |
Lower surface charge, kallikrein-kinase system activation and high-molecular weight protein adsorption than AN69 membrane due to surface treatment technique with cationic polyethyleneimine, specific antithrombin III adsorption by binding to heparin coating, unique self-anticoagulant membrane for heparin-free dialysis |
[27, 69, 70] |
HeprAN membrane |
Copolymer of acrylonitrile and methallylsulfonate (AN69) coated with polyethyleneimine and heparin |
Symmetric |
NA |
45 |
High-flux |
Further superficial treatment by cationic polyethyleneimine polymer and grafting of heparin on the inner surface, specific antithrombin III adsorption by binding to heparin coating, unique self-anticoagulant membrane for heparin-free dialysis, effective endotoxin retention capacity |
[27, 69] |
Vitamin-E coated membrane |
Cellulose-based or polysulfone-based membrane coated with vitamin-E |
NA |
NA |
NA |
Low- to high-flux |
Decreased oxidative stress, improved inflammation status and anemia, persistence of complement activation |
[15, 52, 55, 71, 72] |